Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 455, 604-605 (2 October 2008) | doi:10.1038/455604a; Published online 1 October 2008
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
nature jobs
Postdoctoral Position Studying Immunology
- The University of Chicago
- Chicago, IL
Pharmacology Group Leader
- S*BIO Pte Ltd
- Singapore
Regenerative medicine: Short cut to cell replacement
Robert Blelloch1
Abstract
To make one differentiated cell type from another, a 'stopover' at an undifferentiated state is often required. An alternative method offering an efficient direct route could have implications for disease treatment.
Regenerative medicine aims to repair diseased or damaged tissues by replacing the affected cells with healthy, functional cells of the same type. The prospects of this discipline have been boosted by the promise of embryonic stem (ES) cells, which are pluripotent — that is, they can differentiate into any cell type — and which can be maintained in culture to 'self-renew' indefinitely.
- Robert Blelloch is at the Institute for Regeneration Medicine, Center for Reproductive Sciences, and Department of Urology, University of California, San Francisco, San Francisco, California 94143–0525, USA.
Email: blellochr@stemcell.ucsf.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
New β-cells from old aciniNature Biotechnology News and Views (01 Oct 2008)
HighlightsClinical Pharmacology & Therapeutics News and Views
See all 4 matches for News And ViewsRESEARCH
In vivo reprogramming of adult pancreatic exocrine cells to &bgr;-cellsNature Article (02 Oct 2008)
Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cellsCell Research Original Article

